ALKERMES | 销售和管理费用

Selling And Administration Expenses 更改 日
AbbVie USD 3.32B 291M 2024-03
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
ALKERMES USD 179.75M 9.96M 2024-03
Amgen USD 1.81B 44M 2024-03
Biogen USD 581.5M 27M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Eli Lilly USD 1.84B 88.5M 2024-03
Gilead Sciences USD 1.38B 233M 2024-03
Intra Cellular Therapies USD 113.08M 8.36M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
J&J USD 5.06B 753M 2024-03
Malin Corporation EUR 2.2M 800K 2023-06
Merck USD 2.48B 268M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
Otsuka Holdings JPY 213.75B 16.88B 2024-03
Pfizer USD 3.5B 976M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03



ALKERMES 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.